⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 30 August, 2019    By - Dr Clemens
Impact of 2 Distinct Levels of Mean Arterial Pressure on Near-Infrared Spectroscopy During Cardiac Surgery

AUTHORS: Holmgaard, Frederik BMSc et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1081-1088 BACKGROUND: Near-infrared spectroscopy (NIRS) is used worldwide to monitor regional cerebral oxygenation (rScO2) during cardiopulmonary bypass (CPB). Intervention protocols meant to mitigate cerebral desaturation advocate to increase mean arterial pressure (MAP) when cerebral desaturation occurs. However, […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Gabapentinoid Medications Might Not Be as Benign as You Think

 Authors: Molero Y et al.  BMJ 2019 Jun 12 Multiple adverse behavioral and psychomotor associations are found with these drugs although the effects might be confined to pregabalin. Clinicians often prescribe gabapentin and pregabalin for pain, sleep, and anxiety symptoms, and some view these drugs as safe alternatives to benzodiazepines and opioids in, for example, patients […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time

AUTHORS: Benzon, Honorio T. MD et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1089-1096 BACKGROUND: Patients presenting for surgery may have isolated or combined prolonged activated partial thromboplastin time (aPTT) and/or prothrombin time (PT). In patients not receiving anticoagulants or with no identifiable cause for abnormal clot formation, a […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
One-Third of Pre-Approved Drugs Haven’t Completed FDA Approval Process

I thought this was interesting so I wanted to share it with our readers. By Mark Terry BioSpace In 1992, the U.S. Food and Drug Administration (FDA) developed its Accelerated Approval Program. It was designed to move certain new drugs to the market faster. The Accelerated Approval leans on a surrogate endpoint, which is a marker, such as […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
NSAID use for osteoarthritis may bring on cardiovascular disease

Author: Tauren Dyson People with osteoarthritis who take NSAIDs have a 23 percent higher likelihood of developing cardiac disease compared to people without the condition. File Photo by Kzenon/Shutterstock Nonsteroidal anti-inflammatory drugs that treat inflammation and pain raise the risk of congenital heart disease, heart attack and other conditions for people with osteoarthritis, new findings […]

Read More